The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021–2028. The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person mainly bacteria in the gut. Get Free Sample PDF-https://www.theinsightpartners.com/sample/TIPBT00002233/
The global Human Microbiome Market is forecasted to be worth USD 1,689.5 Million by 2027, according to a current analysis by Emergen Research. The Human Microbiome market is anticipated to grow substantially owing to the rising awareness of human microbiome therapy. The market is also expected to boost by increasing favorable regulations on probiotics and prebiotics by regulatory bodies. Besides, the growing prevalence of chronic diseases is forecasted to further propel the market growth over the forecast timeframe.
The major players covered in the Human Microbiome Therapeutics Market are Seres Therapeutics, Assembly Biosciences, Enterome Bioscience, Vedanta BioSciences, Second Genome Inc... @ @ https://bit.ly/3uW6KCg
The major players covered in the global microbiome market are MicroBiome Therapeutics LLC, Seres Therapeutics, Enterome Bioscience, Second Genome, Vedanta Biosciences Inc.... @ @ https://bit.ly/2QhDxmf
The report on “Global Microbiome Therapeutics Market” is a professional report which provides thorough knowledge along with complete information pertaining to the Microbiome Therapeutics industry a propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc.
This industry study presents the global Microbiome Sequencing Services market size, historical breakdown data (2014-2019) and forecast (2019-2025). The Microbiome Sequencing Services production, revenue and market share by manufacturers, key regions and type
The global microbiome therapeutics market size is expected to grow from $0.29 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 34.7%.
TBRC global human microbiome therapeutics market report includes infectious diseases, gastrointestinal disorders, metabolic disorders, cancers, other diseases
The global microbiome therapeutics market was valued at about $0.31 billion in 2018 and is expected to grow to $1.28 billion at a CAGR of 42.5% through 2022. Read more at http://bit.ly/365HTyI
According to the latest research report by IMARC Group, The global microbiome sequencing services market size reached US$ 1,846.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 5,568.4 Million by 2028, exhibiting a growth rate (CAGR) of 20% during 2023-2028. More Info:- https://www.imarcgroup.com/microbiome-sequencing-services-market
The global fuel cell market size reached USD 4.26 Billion in 2021 and is expected to register a revenue CAGR of 22.8% during the forecast period, according to latest analysis by Emergen Research. Rising adoption of fuel cells in military applications across the globe is the key factor driving revenue growth of the market.
The global mass spectrometry market size reached USD 4.36 Billion in 2021 and is expected to register a revenue CAGR of 6.1% during the forecast period, according to latest analysis by Emergen Research. Increased spending by pharmaceutical companies on research & development activities is a major factor driving market revenue growth. These research activities are also facilitating developments and drawing in investments in biopharmaceutical and personalized medicine.
The global ophthalmic equipment market size was USD 60.49 Billion in 2021 and is expected to register a revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of glaucoma, cataracts, and other ocular conditions, increasing need for Research & Development (R&D) due to prevalence of eye-related diseases, need for improved patient outcomes, and use of cutting-edge technologies are major factors driving market revenue growth.
The global soil testing equipment market size is expected to reach USD 8.36 Billion in 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to growing utilization of soil testing equipment in the construction sector. Increasing construction activities in developing countries and responsibility to ensure safe construction and need for reliable geotechnical soil investigation are contributing to increasing demand for and use of soil testing equipment in the construction sector globally.
Latest research report “Microbiome Therapeutics Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2lZPJZe Request a Sample: http://bit.ly/2kS0eh1
The global Molecular Forensics Market is forecasted to be worth USD 2,223.7 Million by 2027, according to a current analysis by Emergen Research. The market for molecular forensics is growing due to the advancement in technology and the adoption of advanced hybridization technologies for molecular forensics tests. Continuous investment in research and development and favorable regulations will propel the growth of the market. However, factors such as the high cost of techniques and complexities will restrain the market.
Human microbiome market is reaching every doorstep and making the population aware of its evolution, the market is visualizing the trials and acceptance of the tested and licensed products associated with live micro-organisms.
Microbiome Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 150 pages covering 5 major players in the industry.
The ‘Global and Chinese Human Microbiome Therapeutics Industry, 2013–2023 Market Research Report’ is a professional and in-depth study on the current state of the global Human Microbiome Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Microbiome Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
The global microbiome market was valued at about $0.3 billion in 2019 and is expected to grow to $0.7 billion at a CAGR of 21% through 2023. Read More @ https://www.thebusinessresearchcompany.com/report/microbiome-market-global-report-2020-2030-covid-19-implications-and-growth
Bharat Book Bureau provides the report on “Global Human Microbiome-based Drugs Market”, (https://www.bharatbook.com/diagnostics-market-research-reports-644540/human-microbiome-based-drugs-diagnostics-global.html) The report provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
A new market study based on the Microbiome Therapeutics Market designed from various sources which also include porter's five forces analysis research techniques to explore the new opening of the market for the period of 2019-2025. The study also interrogates and examines the information based on share, market size, growth path, and the latest trends to recognize the potential value of the market. And most importantly, the data on the current business scenario will also help players to understand the stakeholder strategies and discover the new opportunities which will help them to succeed in their way.
Loop-mediated Isothermal Amplification (LAMP) Market: Increasing Demand for Point-of-Care Systems for Nucleic Acid Identification to Elevate the Number of Use Cases: Global Industry Analysis (2013-2017) & Opportunity Assessment (2018-2028)
Future Market Insights (FMI), in its latest publication, outlines the future trajectory of the global nucleic acid isolation and purification market through 2029. According to the report, worldwide sales of nucleic acid isolation and purification kits were valued at ~US$ 830 million in 2018, and are estimated to register a Y-o-Y growth of ~4% in 2019.
The report Life Science Tools Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Prebiotics Market size was valued at USD 6.2 billion in 2022 and is estimated to expand at 14.5% CAGR from 2023 to 2032, due to high public demand of awareness of its ability to promote good intestinal health.
The global sports nutrition market is expected to progress with a CAGR of 9.88% during the forecast period of 2024 to 2032. Get more insights into our blog
Market Size – USD 108.4 Billion in 2021, Market Growth – at a CAGR of 6.9%, Market Trends – Inclusion of immune-boosting functional components in nutraceutical products
Rapid advancements and innovation in battery management system technologies and increasing need for battery monitoring in modern renewable energy systems are key factors driving market revenue growth
The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032.
Data Bridge Market Research analyses that the infertility treatment market is expected to undergo a CAGR of 8.03% during the forecast period. This indicates that the market value, which was USD 1.50 billion in 2021, would rocket up to USD 2.78 billion by 2029. “Assisted Reproductive Technology (ART)” dominates the application segment of the infertility treatment market owing to the increasing number of technological advancements, growing awareness about assisted reproductive technology (ART) and increase in funding for research and development into microbiome-based therapies worldwide. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
By product, the global human microbiome market is classified into probiotics, prebiotics, foods, medical foods, supplements, diagnostic devices, and drugs. Download Sample at http://bit.ly/2L7pBDp . The expectation that microbiome products, which will aid in the early-stage treatment of chronic diseases and various disorders, will be available in the market in the future is a key driver for the growth of this market.
According to the latest research report by IMARC Group, The global probiotic dietary supplement market size reached US$ 7.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. More Info:- https://www.imarcgroup.com/probiotic-dietary-supplement-market
The Global Biomaterials Market is projected to reach USD 297.08 billion in 2027. The key factors influencing the market include the growing geriatric population, acceleration in chronic disorders such as cardiovascular disorders, orthopedic disorders, and an upsurge in the sports injuries, which are anticipated to impel the market in the forecast period. A higher traction of these materials are being observed in the usage of interacting with biological systems designed for medical treatments for correcting cardiovascular, orthopedic, neurological disorders, and dental, among others.
he global HR analytics market size was USD 3.10 Billion in 2021 and is expected to register a revenue CAGR of 15.0% during the forecast period, according to the latest analysis by Emergen Research. Growing adoption of HR analytics among large, medium, and small size enterprises to make data-driven decisions is a major factor projected to support market revenue growth between 2022 and 2030.
The global Wi-Fi 6 devices market size is expected to reach USD 27.42 Billion in 2028, and register a CAGR of 25.1% during the forecast period. Market revenue growth is primarily driven by rising demand for high-speed wireless connectivity owing to benefits of instant network traffic routing offered by Wi-Fi 6. These devices are effective for even remote devices in crowded networks. Wi-Fi 6 provides reliable connectivity solutions, to a very large network traffic volume, thereby allowing for higher number of smartphones, laptops, cameras, displays, smart speakers, and other Internet of Things (IoT) and personal devices to be seamlessly connected and communicate with each other.
The global Glycomics/Glycobiology market size reached USD 1.51 Billion in 2021 and is expected to register a revenue CAGR of 15.4% during the forecast period, according to latest analysis by Emergen Research. Increasing application of quantitative glycomics in clinical settings, rising potential of glycan biomarkers for prognosis and diagnosis of various diseases, as well as rapid technological advancements in glycomics/glycobiology field such as high-throughput serum glycomic profiling are some of the key factors driving the market revenue growth of the Glycomics/Glycobiology market.
The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period, according to latest analysis by Emergen Research.
The global master data management market size was USD 14.83 Billion in 2021 and is expected to register a revenue CAGR of 15.5% during the forecast period, according to latest analysis by Emergen Research. Rising incorporation of advanced technologies, such as big data and Artificial Intelligence (AI) with Master Data Management (MDM), is driving revenue growth of the market.
The global Endoscopic Retrograde Cholangiopancreatography (ERCP) market size was USD 1.40 Billion in 2022 and is expected to register a rapid revenue CAGR of 4.3% during the forecast period, according to latest analysis by Emergen Research. Surge in procurement of endoscopy devices in healthcare facilities and rapid increase in popularity of minimally invasive surgeries are key factors driving market revenue growth.
The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a revenue CAGR of 7.8% during the forecast period, according to the latest analysis by Emergen Research. One of the main factors driving revenue growth of the market is significant developments in biomedical devices and replacement of conventional methods due to creation of better patient monitoring facilities. Increasing use of wearable and remote patient monitoring devices is another factor driving revenue growth of the market.
The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry.
The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.